结直肠手术市场归因于频繁的诊断测试和医疗设备的推出。大多数主要市场参与者都参与制造各种有助于减轻结直肠癌和其他相关适应症(如结肠息肉、克罗恩病、结肠炎、肠易激综合症等)负担的设备。例如,2020年4月,奥林巴斯公司宣布推出最先进的内窥镜EVIS X1。该系统有助于改善胃、结肠、食道和支气管疾病的结果。该系统具有扩展景深(EDOF)、红色二色成像(RDI)、纹理和色彩增强成像(TXI)以及窄带成像(NBI)等多种功能。 EVIS X1 的推出巩固了奥林巴斯在内窥镜和医疗器械行业的领导地位。
2022 年 7 月,美国消化健康 (USDH) 网络评价最高胃肠 (GI) 诊所宣布将人工智能辅助结肠镜检查商业化,安装了全国最大的 GI Genious 智能内窥镜模块。它将帮助医生实时识别难以检测和潜在癌变的息肉。该设备的推出将使宾夕法尼亚州东南部、西南部和中部的患者能够广泛接触到这项创新技术及其增强的功能。此外,2020年9月,奥林巴斯公司宣布推出ENDO-AID,这是一个由人工智能(AI)驱动的尖端平台,其中包括用于结肠的内窥镜应用ENDO-AID CADe(计算机辅助检测)。这个新的人工智能平台能够实时显示自动检测到的可疑病变,并与最近推出的 EVIS X1 结合使用。因此,结直肠相关适应症的不断发展和新产品的推出正在推动结直肠手术市场的增长。
北美 北美结直肠手术市场分为美国、加拿大和墨西哥。北美是全球结直肠手术市场的主导地区。这一增长可归因于与年龄相关的问题、政府资金的增加以及区域技术的持续改进。由于全国结直肠癌发病率显着上升以及政府对结肠癌研究的支持不断增加,预计该地区的北美结直肠手术市场将会增长。此外,政府还提供多项计划来改善人民的生活。
北美结直肠手术市场细分
北美结直肠手术市场分为产品、手术类型、适应症、最终用户和国家。
<根据产品路线,北美结直肠手术市场分为内窥镜、电外科、手持设备和视觉系统、密封和缝合设备、结扎夹和扩张器和窥镜、切割器和剪刀、配件和其他的。 2022 年,内窥镜细分市场在北美结直肠手术市场中占据最大份额。
根据手术类型,北美结直肠手术市场分为右半结肠切除术、左半结肠切除术、结肠次全切除术、低位前切除术、腹会阴切除术等(包括内窥镜手术)。 2022 年,结肠次全切除术在北美结直肠手术市场中占据最大份额。
根据最终用户,北美结直肠手术市场分为医院和医院。诊所、手术中心等。 2022年,医院和诊所在北美结直肠手术市场中占据最大份额。
根据适应症,北美结直肠手术市场分为结肠息肉、克罗恩病疾病、结直肠癌、结肠炎、肠易激综合症和其他适应症。 2022 年,肠易激综合征细分市场在北美结直肠手术市场中占据最大份额。
根据国家/地区,北美结直肠手术市场分为美国、加拿大、和墨西哥。 2022 年,美国在北美结直肠手术市场占据主导地位。
Ethicon(强生服务公司);美敦力;科洛斯潘有限公司;安全治疗; B.布劳恩·梅尔松根;康德乐健康公司;波士顿科学公司;库珀外科有限公司;奥林巴斯公司是北美结直肠手术市场上的一些领先公司。
Strategic insights for North America Colorectal Procedure involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 6,311.66 Million |
Market Size by 2028 | US$ 12,946.28 Million |
Global CAGR (2022 - 2028) | 12.7% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Colorectal Procedure refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Colorectal Procedure Market is valued at US$ 6,311.66 Million in 2022, it is projected to reach US$ 12,946.28 Million by 2028.
As per our report North America Colorectal Procedure Market, the market size is valued at US$ 6,311.66 Million in 2022, projecting it to reach US$ 12,946.28 Million by 2028. This translates to a CAGR of approximately 12.7% during the forecast period.
The North America Colorectal Procedure Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Colorectal Procedure Market report:
The North America Colorectal Procedure Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Colorectal Procedure Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Colorectal Procedure Market value chain can benefit from the information contained in a comprehensive market report.